GlassScriptPhysician profile
Michael L Suminski
NPI 1578606109
$698.84
in general payments reported to CMS, 2019-2025
17 companies · $131 in 2025
The $131 reported for 2025 was less than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $53.37 · 2020: $14.10 · 2021: $92.41 · 2022: $85.06 · 2023: $166 · 2024: $157 · 2025: $131.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $365 · Education: $88.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $364.91 |
| Education | $88.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $109.21 | 2023 | Myrbetriq |
| Coloplast Corp | $92.17 | 2020-2024 | Speedicath |
| Sumitomo Pharma America, INC. | $78.82 | 2025 | Orgovyx |
| Tolmar Pharmaceuticals, INC. | $54.27 | 2021 | |
| Convatec INC. | $47.86 | 2022-2023 | |
| Pfizer INC. | $44.63 | 2024 | |
| Urogen Pharma, INC. | $39.51 | 2022 | |
| Axonics, INC. | $37.83 | 2024 | Axonics |
| C. R. Bard, INC. & Subsidiaries | $33.30 | 2019 | |
| Verity Pharmaceuticals INC. | $27.04 | 2025 | Trelstar |
| Inspire Medical Systems, INC. | $24.94 | 2025 | Inspire |
| Ferring Pharmaceuticals INC. | $24.82 | 2024 | Adstiladrin |
| Sun Pharmaceutical Industries INC. | $20.75 | 2024 | |
| Olympus America INC. | $20.07 | 2019 | |
| Laborie Medical Technologies Corp. | $16.46 | 2022 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bayer Healthcare Pharmaceuticals INC. | $13.68 | 2024 | |
| Endo Pharmaceuticals INC. | $13.48 | 2023 | Xiaflex |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michael Suminski listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.